Dear Colleagues,
Please join the FH Foundation for the
FH Global Summi
t
(October 1 & 2, 2018), as we discuss, debate and develop meaningful solutions to some of the most pressing global challenges in familial hypercholesterolemia (FH). Please take a moment to view the
world class speakers
and the variety of
sessions
scheduled for this year's convening, including…
Care and Economics: A Sometimes Messy Intersection
We are entering a new era where determinations of costs and value of health technologies – whether diagnostic tests or innovative therapies -- are becoming important considerations in healthcare decision making worldwide. Clinical care that a physician provides to a patient increasingly occurs within the context of payer policies on coverage, reimbursement, and utilization management of health technologies. How are these determinations made and what can we do to ensure that the needed data, expertise, perspectives, and incentives are available for appropriate healthcare decision making? It’s why I am excited to moderate “Clinical Care and Economics: A Sometimes Messy Intersection” at the FH Global Summit.
We are bringing together global experts in health economics and policy research. We will hear about and discuss how value assessments of health technologies have emerged in the U.S. and ex-U.S. settings, what evidence exists specifically on the value of FH screening strategies and treatments, and what tools payers are using to manage utilization of technologies with questionable value or high budget impact. Most importantly, how does this impact access for FH patients and what are the implications of delayed care?
• Joel W. Hay, PhD
• Finn Børlum Kristensen, MD, PhD
• Roger Longman
• Kelly Myers
You don’t want to miss this informative session!
